Poland· PL-100332911

Brimica Genuair

A formoterol und aclidinium bromid product containing aclidinium + formoteroli fumaras, registered in Poland by Covis Pharma Europe B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC R03AL05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBrimica GenuairATCR03AL05REGISTER NO.PL-100332911PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Formoterol und aclidinium bromid is registered in 10 of 19 countries.

Countries holding a registration under ATC R03AL05 (formoterol und aclidinium bromid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Formoterol und aclidinium bromid · ATC R03AL05

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Aclidinium + Formoteroli fumaras
Manufacturer
Covis Pharma Europe B.V.
Country
Poland (PL)
ATC code
R03AL05
ATC class
Formoterol und Aclidinium bromid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05000456010924

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Formoterol und aclidinium bromid in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All formoterol und aclidinium bromid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Brimica Genuair, Duaklir Genuair
  • Liechtenstein · Brimica Genuair, Duaklir Genuair
  • Norway · Brimica Genuair, Duaklir Genuair

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/607fc092-62b1-4a80-aaaa-f9a1cb424e3f
GET /v1/drugs/607fc092-62b1-4a80-aaaa-f9a1cb424e3f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do inhalacji",
  "source": "urpl",
  "strength": "340 mcg + 12 mcg",
  "packaging": "05000456010924 ¦ Rp ¦ EU/1/14/963/001 ¦ 105994\n1 inhalator 60 dawek\nRp ¦ EU/1/14/963/002 ¦ 105995\n3 inhalatory 60 dawek\nRp ¦ EU/1/14/963/003 ¦ 119449\n1 inhalator 30 dawek",
  "substance": "Aclidinii bromidum 340 mcg + Formoteroli fumaras dihydricus 12 mcg",
  "common_name": "Aclidinium + Formoteroli fumaras",
  "pl_product_id": "100332911",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

See everything about formoterol und aclidinium bromid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.